ABO zygosity, but not secretor or Fc receptor status, is a significant risk factor for IVIG-associated hemolysis

Affiliations

• ¹ Department of Medicine and.
• ² Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada.
• ³ Centre for Innovation, Canadian Blood Services, Toronto, ON, Canada.
• ⁴ Division of Hematology and Transfusion Medicine, Department of Laboratory Medicine, Lund University, Lund, Sweden.
• ⁵ Department of Clinical Immunology and Transfusion Medicine, Laboratory Medicine, Office of Medical Services, Region Skåne, Lund, Sweden.
• ⁶ Department of Blood Cell Research, Sanquin Research and Landsteiner Laboratory, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands.
• ⁷ Laboratory Medicine Program, University Health Network, Toronto, ON, Canada.
• ⁸ Department of Clinical Pathology, Sunnybrook Health Sciences Centre, Toronto, ON, Canada.
• ⁹ Department of Laboratory Medicine, St. Michael's Hospital, Toronto, ON, Canada.
• ¹⁰ Institut Universitaire de Cardiologie et Pneumologie de Québec and CHU de Québec and Hôpitaux Enfant-Jésus et Saint-Sacrement, Québec City, QC, Canada.
• ¹¹ Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, Toronto, ON, Canada.
• ¹² Canadian Blood Services, Toronto, ON, Canada.
• ¹³ Department of Transfusion Medicine, Pediatric Laboratory Medicine, Hospital for Sick Children, Toronto, ON, Canada.
• ¹⁴ Pediatric Hematology, Immunology, Rheumatology, and Infectious Diseases, Emma Children's Hospital, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands.